Peregrine Capital Management’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
CB
Peregrine Capital Management's CNMD Position: Q4 2025 in Review
Peregrine Capital Management sold out of CONMED (CNMD) in Q4 2025, closing a stake of 1,223 shares — an estimated $57.5K sold.
Peregrine Capital Management first reported a position in CNMD in Q4 2020 and held it in 20 quarters. The position peaked at $21.3M in Q2 2021. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2025.
- Peregrine Capital Management reported no remaining CONMED position as of Q4 2025 after selling out during the quarter.
- Peregrine Capital Management sold 1,223 CONMED shares in Q4 2025, an estimated $57.5K.
- Peregrine Capital Management first reported a position in CONMED in Q4 2020 and held it in 20 quarters.
- Peregrine Capital Management's CONMED position peaked at $21.3M in Q2 2021.
- 265 funds tracked by Wall St. Rank held CONMED as of Q4 2025.
Based on Peregrine Capital Management's 13F filing for Q4 2025, filed 28 Jan 2026.